Symproic Tablet
Product Images NDC 59385-041

5 FDA label images from Biodelivery Sciences International Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Symproic (NDC 59385-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biodelivery Sciences International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Symproic 01)

Chemical Structure (Symproic 01)
Chemical structure of naldemedine, the active ingredient in SYMPROIC. The diagram shows the molecular framework with multiple rings, hydroxyl groups, and a sulfonic acid group attached to a benzene ring.*
FDA Label Image

Figure 1 (Symproic 02)

Figure 1 (Symproic 02)
A bar chart depicting the effect of different CYP3A/P-gp inducers and inhibitors on drug exposure. It shows relative changes for Cmax (filled squares) and AUC (open circles) with 90% confidence intervals for rifampin (strong inducer), itraconazole (strong inhibitor), fluconazole (moderate inhibitor), and cyclosporine (P-gp/weak inhibitor). The x-axis represents change relative to reference on a scale from 0 to 3, with corresponding ratio values provided on the right side.*
FDA Label Image

Principal Display Panel (0.2 mg Tablet Bottle Label)

Principal Display Panel (0.2 mg Tablet Bottle Label)
Symproic 0.2 mg tablets label showing naldemedine as the active ingredient. The label indicates 30 tablets per container, with storage instructions for light-resistant conditions and room temperature. Manufactured by BioDelivery Sciences International Inc, Raleigh, NC. The label includes a note to dispense the enclosed medication guide to patients and displays the product NDC 59385-041-30.*
FDA Label Image

Principal Display Panel (0.2 mg Tablet Blister Pack)

Principal Display Panel (0.2 mg Tablet Blister Pack)
Symproic (naldemedine) tablets 0.2 mg, oral dosage form. The label indicates a carton or blister packaging containing 7 tablets. Each tablet contains 0.2 mg of naldemedine. The label includes storage instructions, manufacturer information for BioDelivery Sciences International, Inc., and notes that the product is prescription-only and physician samples are not for sale.*
FDA Label Image

Principal Display Panel (0.2 mg Tablet Blister Pack Carton)

Principal Display Panel (0.2 mg Tablet Blister Pack Carton)
Packaging label for SYMPROIC (naldemedine) tablets 0.2 mg by BioDelivery Sciences International Inc. The carton indicates a supply of 7 tablets for oral use only. The label specifies dosage as one tablet once daily and marks the product as physician samples not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.